Clinical trials for Stomach and esophageal cancer

118 currently recruiting clinical trials
Early Access Stomach and esophageal cancer
Stomach Oesogastric junction Adenocarcinoma Locally Advanced Metastatic HER2 PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) None Systemic Treatment-Naive
MSD
Merck Sharp & Dohme LLC
Early Access Stomach and esophageal cancer
Stomach Oesogastric junction Adenocarcinoma Locally Advanced Metastatic Claudin 18.2 PDL1 Negative (< 1%) None Systemic Treatment-Naive
HER2
Astellas
Astellas Pharma Développement mondial, Inc.
Phase 3 Colon cancer Rectal cancer Pancreas cancer Stomach and esophageal cancer #NCT06937905
Neuroendocrine tumor Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive
Centre Hospitalier d'Avignon (Avignon), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Hospitalier Universitaire Laennec (Saint-Herblain), Centre Hospitalier Intercommunal Toulon/La Seyne - Hôpital Georges Sand (La Seyne-sur-mer), Hôpital Trousseau - CHRU Hôpitaux de Tours (Chambray-lès-Tours) (and 32 more...)
Intergroupe Francophone de Cancérologie Thoracique
Phase 3 Colon cancer Rectal cancer Pancreas cancer Stomach and esophageal cancer #NCT06937905
Neuroendocrine tumor Locally Advanced Metastatic 1 Chemotherapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Besançon (Besançon), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier), Centre Hospitalier d'Avignon (Avignon), Centre hospitalier universitaire François Mitterrand (Dijon), Hôpital de la Timone AP-HM (Marseille) (and 34 more...)
Intergroupe Francophone de Cancérologie Thoracique
Phase 3 Stomach and esophageal cancer #NCT07270991 #2025-522395-92-00
Stomach Oesogastric junction Esophagus Adenocarcinoma Metastatic 2 3 or more Chemotherapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Clinique de Flandre - Elsan (Coudekerque-Branche)
Fédération Francophone de Cancérologie Digestive
Phase 3 Stomach and esophageal cancer #NCT07043400 #2025-522862-58-00
Stomach Oesogastric junction Adenocarcinoma Locally Advanced Metastatic None Systemic Treatment-Naive
HER2
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Institut Sainte Catherine (Avignon)
BeOne Medecines
Phase 3 Pancreas cancer Stomach and esophageal cancer #NCT05477576 #2023-509334-19-00
Stomach Neuroendocrine tumor Locally Advanced Metastatic 1
Systemic Treatment-Naive
Hôpital Beaujon (Clichy), CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
RayzeBio, Inc
Phase 3 Stomach and esophageal cancer #NCT06346197 #2023-506291-28-00
Stomach Oesogastric junction Esophagus Adenocarcinoma Locally Advanced Metastatic MSI/dMMR PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) None Systemic Treatment-Naive
HER2 Immunotherapy Immunotherapy
Centre Léon Bérard (Lyon), Institut Paoli-Calmettes (Marseille)
Centre Léon Bérard
Phase 3 Colon cancer Rectal cancer Anal cancer Pancreas cancer Stomach and esophageal cancer #NCT07087054 #2024-519875-24-00
Neuroendocrine tumor None
Hôpital de la Timone AP-HM (Marseille), Hôpital Trousseau - CHRU Hôpitaux de Tours (Chambray-lès-Tours), Centre Antoine Lacassagne (Nice), Centre Hospitalier Universitaire de Nantes (Nantes), Hôpital Beaujon (Clichy) (and 1 more...)
Crinetics Pharmaceuticals Inc.
Phase 3 Stomach and esophageal cancer #NCT06901531 #2024-519773-19-00
Stomach Oesogastric junction Adenocarcinoma Locally Advanced Metastatic Claudin 18.2 PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) None Systemic Treatment-Naive
HER2 Immunotherapy Chemotherapy
Centre Hospitalier Universitaire de Lille (Lille), Hôpital Saint Louis AP-HP (Paris), Centre Henri Becquerel (Rouen ), CHU Caen Normandie (Caen), Hôpital Saint Antoine AP-HP (Paris) (and 13 more...)
Astellas Pharma Développement mondial, Inc.